DelveInsight is a prominent provider of valuable research within biotech and pharmaceutical industries. It offers analytical reports in such Health Care sectors as gene therapy, medical oncologic therapy, Active Pharmaceutical Ingredient (API) manufacturing, stem cell medication, biosimilars, orphan drugs and others. The expertise includes:
- Company’s profile and licensing data;
- New technology studies;
- Biologic benchmarking;
- Treatment modality analysis;
- Competitive landscape;
- Product assessment; etc.
This knowledge is essential for Generic and Drug Development companies, which also receive drug sales estimation and product performance forecasts.
DelveInsight reconciles customers need for information and for innovative approaches in business development. Consequently, the obtained data is turned into strategic design, partner up opportunities, profit earning capacity of the business. DelveInsight analysts assist pharma enterprises in launching new products and marketing development of existing pharmaceutics.
Publications found:
6,889
Sort by:
NT-814 - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “NT-814 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Vas...
February 2021
30 pages
ODEVIXIBAT - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “ODEVIXIBAT - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for...
February 2021
30 pages
Perampanel - Emerging Insights and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “Perampanel- Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for...
February 2021
30 pages
PF-06755347 - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “PF-06755347 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product fo...
February 2021
30 pages
PIMAVANSERIN - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “PIMAVANSERIN - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product f...
February 2021
30 pages
PLG0206 - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “PLG0206 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Pr...
February 2021
30 pages
PSILOCYBIN - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “PSILOCYBIN - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for...
February 2021
30 pages
RC18 - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “RC18 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Sjogr...
February 2021
30 pages
REC 0/0559 - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “REC 0/0559 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for...
February 2021
30 pages
REL-1017 - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “REL-1017 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for M...
February 2021
30 pages
RGN-259 - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “RGN-259 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Pe...
February 2021
30 pages
RSLV-132 - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “RSLV-132 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for S...
February 2021
30 pages
SELTOREXANT- Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “SELTOREXANT- Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for...
February 2021
30 pages
SETANAXIB - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “SETANAXIB - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for...
February 2021
30 pages
ST266 - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “ST266 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Pers...
February 2021
30 pages
TAK935 - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “TAK935- Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Lenn...
February 2021
30 pages
TNP-2092 - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “TNP-2092 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for P...
February 2021
30 pages
VIB4920 - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “VIB4920 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Sj...
February 2021
30 pages
VOCLOSPORIN - Emerging Insight and Market Forecast - 2030
US$ 3,250.00
This report can be delivered to the clients within 48 Hours “VOCLOSPORIN - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product fo...
February 2021
30 pages
Bronchitis– Pipeline Insight, 2020
US$ 1,500.00
... clients within 48 Hours 'Bronchitis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Bronchitis development. The report provides detailed ...
November 2020
60 pages
Dysmenorrhea – Pipeline Insight, 2020
US$ 1,500.00
... clients within 5 Days 'Dysmenorrhea - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Dysmenorrhea development. The report provides detailed ...
November 2020
60 pages
Varicella Zoster (HHV-3) Infections - Pipeline Insight, 2020
US$ 1,500.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Varicella Zoster (HHV-3) Infections The report also ...
November 2020
50 pages
Helicobacter Pylori Infections - Pipeline Insight, 2020
US$ 1,500.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Helicobacter Pylori Infections The report also ...
November 2020
60 pages
GABA Receptor Antagonists – Pipeline Insight, 2020
US$ 1,500.00
... not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details. Pipeline Therapeutics assessment of products for “GABA Receptor Antagonist The report assesses ...
November 2020
60 pages
STAT Inhibitors – Pipeline Insight, 2020
US$ 2,500.00
... methyl of Reata Pharmaceuticals. Products covered by Phase Phase III, Phase II, Phase I IND Pre-clinical & Discovery Inactive (Dormant and Discontinued) Overview of pipeline development activities for STAT Inhibitors Pipeline analysis of therapeutic drugs include but ...
November 2020
150 pages
Lymphangioleiomyomatosis (LAM) - Pipeline Insight, 2020
US$ 1,500.00
This report can be delivered to the clients within 24-48 Hours DelveInsight’s, “Lymphangioleiomyomatosis– Pipeline Insight, 2020,” report provides comprehensive insights about 10+ companies and 10+...
November 2020
60 pages
Anemia In Chronic Kidney Disease - Pipeline Insight, 2020
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Anemia in Chronic Kidney Disease – Pipeline Insight, 2020,” report provides comprehensive insights about 10+ companies...
November 2020
60 pages
Prostate Cancer – Pipeline Insight, 2020
US$ 5,000.00
This report can be delivered to the clients within 5 Business days DelveInsight’s, “Prostate Cancer – Pipeline Insight, 2020,” report provides comprehensive insights about 900+ companies and 900+ pi...
November 2020
350 pages
Severe Hypoglycemia – Pipeline Insight, 2020
US$ 2,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Severe Hypoglycemia – Pipeline Insight, 2020,” report provides comprehensive insights about 30+ companies and 30+ pipe...
November 2020
80 pages
Spinocerebellar Ataxias - Pipeline Insight, 2020
US$ 1,500.00
This report can be delivered to the clients within 24-48 Hours DelveInsight’s, “Spinocerebellar Ataxias – Pipeline Insight, 2020,” report provides comprehensive insights about 3+ companies and 3+ pi...
November 2020
50 pages
NF-kappa B Inhibitors – Pipeline Insight, 2020
US$ 2,500.00
This report can be delivered to the clients within 72 Hours DelveInsight’s, “NF-kappa B Inhibitors – Pipeline Insight, 2020,” report provides comprehensive insights about 90+ companies and 90+ pipel...
November 2020
150 pages
Acute Radiation Syndrome – Pipeline Insight, 2020
US$ 1,500.00
This report can be delivered to the clients within 48-72 Hours DelveInsight’s, “Acute Radiation Syndrome – Pipeline Insight, 2020,” report provides comprehensive insights about 10+ companies and 10+...
November 2020
60 pages
Alzheimer's disease (AD) - Pipeline Insight, 2020
US$ 3,000.00
This report can be delivered to the clients within 5 Business Days DelveInsight’s, “Alzheimer’s Disease (AD) – Pipeline Insight, 2020,” report provides comprehensive insights about 100+ companies an...
November 2020
130 pages
